Article
Targeting pathogenic Lafora bodies in Lafora disease using an antibody-enzyme fusion
2019-06-21
Abstract excerpt
Lafora disease (LD) is a fatal childhood epilepsy and a non-classical glycogen storage disorder with no effective therapy or cure. LD is caused by recessive mutations in the EPM2A or EPM2B genes that encode the glycogen phosphatase laforin and an E3 ubiquitin ligase malin, respectively. A hallmark of LD is the intracellular accumulation of abnormal and insoluble α-linked polysaccharide deposits known as Lafora b...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 96128388-9aac-53ff-9af8-29ecbc8aa269
- DOI
- 10.1101/679407
